4//SEC Filing
Gaston-Dreyfus Remi 4
Accession 0001104659-23-073229
CIK 0001508381other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 10:57 AM ET
Size
5.9 KB
Accession
0001104659-23-073229
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Purchase
Common Stock, par value $0.001 per share
2023-06-09$0.60/sh+180,555$108,333→ 1,814,871 total(indirect: Shares held through GD Holdings and Lombard International Assurance SA)
Holdings
- 61,256
Common Stock, par value $0.001 per share
Footnotes (2)
- [F1]The reporting person acquired the shares of common stock in lieu of cash payment of $108,333 in accrued and unpaid fees relating to reporting person's services as a director of the Issuer.
- [F2]Includes 17,476 exchangeable shares of the Issuer's subsidiary.
Documents
Issuer
Bionik Laboratories Corp.
CIK 0001508381
Entity typeother
Related Parties
1- filerCIK 0001716639
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 10:57 AM ET
- Size
- 5.9 KB